Navigation Links
NBTY Announces Agreement to Purchase Leiner Health Products

RONKONKOMA, N.Y., June 10 /PRNewswire-FirstCall/ -- NBTY, Inc. (NYSE: NTY) (, a leading global manufacturer and marketer of nutritional supplements, today announced it submitted the best and highest bid at an auction held on June 9, 2008 for the purchase of substantially all of the assets of Leiner Health Products, Inc. ("Leiner").

In connection with the auction, NBTY entered into an amended and restated Asset Purchase Agreement (the "Agreement") for the purchase of substantially all of the assets of Leiner for approximately $371 million plus assumption of certain liabilities. The Agreement provides for a downward purchase price adjustment if the amount of actual working capital at the closing is less than $110 million, and for an upward purchase price adjustment if the amount of actual working capital at closing is greater than $110 million.

The Agreement is subject to the approval of the bankruptcy court presiding over Leiner's chapter 11 bankruptcy proceedings. The purchase transaction is also subject to regulatory and other customary approvals and customary closing conditions. NBTY expects to consummate the acquisition by no later than September 2008.

NBTY Chairman and CEO, Scott Rudolph, said: "The Leiner acquisition reflects our ongoing efforts to better meet the needs of our customers by providing them with the highest quality service and continuous product supply. We continue to seek acquisitions which will enhance our position as the worldwide leader in the nutritional supplement industry and further our ongoing efforts to generate growth and increase shareholder value."


NBTY is a leading global vertically integrated manufacturer, marketer and distributor of a broad line of high-quality, value-priced nutritional supplements in the United States and throughout the world. Under a number of NBTY and third party brands, the Company offers over 22,000 products, including products marketed by the Company's Nature's Bounty(R) (, Vitamin World(R) (, Puritan's Pride(R) (, Holland & Barrett(R) (, Rexall(R) (, Sundown(R) (, MET-Rx(R) (, Worldwide Sport Nutrition(R) (, American Health(R) (, GNC (UK)(R) (, DeTuinen(R) (, LeNaturiste(TM) (, SISU(R) (, Solgar(R) (, Good 'n' Natural(R) (, Home Health(TM) ( and Ester-C(R) ( brands.

This release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 with respect to our financial condition, results of operations and business. These forward-looking statements can be identified by the use of terminology such as "subject to," "believe," "expects," "plan," "project," "estimate," "intend," "may," "will," "should," "can," or "anticipates," or the negative thereof, or variations thereon, or comparable terminology, or by discussions of strategy. Although all of these forward looking statements are believed to be reasonable, they are inherently uncertain. Factors which may materially affect such forward-looking statements include: (i) slow or negative growth in the nutritional supplement industry; (ii) interruption of business or negative impact on sales and earnings due to acts of God, acts of war, terrorism, bio-terrorism, civil unrest or disruption of mail service; (iii) adverse publicity regarding nutritional supplements; (iv) inability to retain customers of companies (or mailing lists) recently acquired; (v) increased competition; (vi) increased costs; (vii) loss or retirement of key members of management; (viii) increases in the cost of borrowings and/or unavailability of additional debt or equity capital; (ix) unavailability of, or inability to consummate, advantageous acquisitions in the future, including those that may be subject to bankruptcy approval or the inability of NBTY to integrate acquisitions into the mainstream of its business; (x) changes in general worldwide economic and political conditions in the markets in which NBTY may compete from time to time; (xi) the inability of NBTY to gain and/or hold market share of its wholesale and/or retail customers anywhere in the world; (xii) unavailability of electricity in certain geographical areas; (xiii) the inability of NBTY to obtain and/or renew insurance and/or the costs of the same; (xiv) exposure to and expense of defending and resolving product liability and intellectual property claims and other litigation; (xv) the ability of NBTY to successfully implement its business strategy; (xvi) the inability of NBTY to manage its retail, wholesale, manufacturing and other operations efficiently; (xvii) consumer acceptance of NBTY's products; (xviii) the inability of NBTY to renew leases for its retail locations; (xix) the inability of NBTY's retail stores to attain or maintain profitability; (xx) the absence of clinical trials for many of NBTY's products; (xxi) sales and earnings volatility and/or trends for the Company and its market segments; (xxii) the efficacy of NBTY's Internet and on-line sales and marketing strategies; (xxiii) fluctuations in foreign currencies, including the British pound, the Euro and the Canadian dollar; (xxiv) import-export controls on sales to foreign countries; (xxv) the inability of NBTY to secure favorable new sites for, and delays in opening, new retail and manufacturing locations; (xxvi) introduction of and compliance with new federal, state, local or foreign legislation or regulation or adverse determinations by regulators anywhere in the world (including the banning of products) and more particularly Good Manufacturing Practices in the United States, the Food Supplements Directive and Traditional Herbal Medicinal Products Directive in Europe and Section 404 requirements of the Sarbanes-Oxley Act of 2002; (xxvii) the mix of NBTY's products and the profit margins thereon; (xxviii) the availability and pricing of raw materials; (xxix) risk factors discussed in NBTY's filings with the U.S. Securities and Exchange Commission; (xxx) adverse effects on NBTY as a result of increased energy prices and potentially reduced traffic flow to NBTY's retail locations; (xxxi) adverse tax determinations; (xxxii) the loss of a significant customer of the Company; (xxxiii) potential investment losses as a result of liquidity conditions; and (xxxiv) other factors beyond the Company's control.

Readers are cautioned not to place undue reliance on forward-looking statements. NBTY cannot guarantee future results, trends, events, levels of activity, performance or achievements. NBTY does not undertake and specifically declines any obligation to update, republish or revise forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrences of unanticipated events.

Consequently, such forward-looking statements should be regarded solely as NBTY's current plans, estimates and beliefs.

Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. CorVel Announces Record Earnings
2. SUA Insurance Company Announces Partnership With American Safety Indemnity Company
3. WellPoint Announces Appearance at Upcoming Conference
4. MINRAD International, Inc. Announces FDA Approval of Petrem(TM) Sevoflurane
5. Synthetech Announces Appointment of Dr. Gregory R. Hahn as President and Chief Executive Officer
6. Mylan Announces Final FDA Approval for Zaleplon Capsules
7. PharMEDium Announces National Rollout of Electronic 222 Ordering Initiative
8. Senetek PLC Announces Key Personnel Appointments
9. QLT announces agreement to sell Aczone(R) to Allergan for approximately US$150 million
10. Health Robotics Announces IV Station (TM Pending) a Centrally-Controlled,
11. Universal Health Realty Income Trust Announces Dividend Increase
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... ... annual fundraising campaign to raise funds for its research, education, support, and advocacy ... the organization’s annual funding. , The Mesothelioma Applied Research Foundation, which also goes ...
(Date:11/30/2015)... ... November 30, 2015 , ... The Progressive Dental Institute ... January 29 and 30, 2016. The course welcomes dental professionals and members of ... learn how to better succeed in the modern dental marketplace. The course combines ...
(Date:11/30/2015)... Miami, FL (PRWEB) , ... November 30, 2015 ... ... added a comparison chart and ingredient list of its hemorrhoid ointment to its ... “fast, effective pain relief for people suffering from hemorrhoids. Adding the comparison chart ...
(Date:11/30/2015)... ... 30, 2015 , ... Advocare Orthopedic and Sports Medicine Center’s ... by John Vitolo, M.D., the center offers their patients the highest quality orthopedic ... & Sports Medicine is ready to help their patients return to their active ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... Newly reviewed ... His grandfather graduated from Tufts School of Dental Medicine in 1935. His ... for the Isola family being in dentistry as well as their commitment and passion ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO ) announced ... Press as a Top Workplace , among the best ... for in 2015. ... based on employee surveys rating company leadership, career opportunities, workplace ... solely on employee feedback. The survey is conducted by WorkplaceDynamics, ...
(Date:11/30/2015)... , Nov. 30, 2015 Next week, December ... of Things (DoT ) co-located events covering the latest ... Internet of Things, will draw more than 3,000 design ... Convention Center. The events, combined show floor will ... --> --> ...
(Date:11/30/2015)... 30, 2015   Royal Philips (NYSE: ... industry,s first MRI guided user interface and automatic scan ... with MR Conditional implants, such as knee and hip ... Radiological Society of North America Annual Meeting (RSNA) . ... diagnostic confidence of this growing patient population. ScanWise Implant ...
Breaking Medicine Technology: